Drug Class
EGFR inhibitor
Type
ingredient
Active Ingredient
cetuximab
📋Overview
Cetuximab is a monoclonal antibody that targets the epidermal growth factor receptor (EGFR) on the surface of certain cells. It is primarily associated with the management of specific types of cancers, including colorectal cancer and head and neck cancers. By binding to EGFR, cetuximab can interfere with signals that promote cancer cell growth and survival. Its use is often considered in cases where tumors express EGFR or have certain genetic characteristics.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Cetuximab
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.